Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
1998-2-2
pubmed:abstractText
The efficient introduction of somatic mutations in a given gene, at a given time, in a specific cell type will facilitate studies of gene function and the generation of animal models for human diseases. We have shown previously that conditional recombination-excision between two loxP sites can be achieved in mice by using the Cre recombinase fused to a mutated ligand binding domain of the human estrogen receptor (Cre-ERT), which binds tamoxifen but not estrogens. DNA excision was induced in a number of tissues after administration of tamoxifen to transgenic mice expressing Cre-ERT under the control of the cytomegalovirus promoter. However, the efficiency of excision varied between tissues, and the highest level ( approximately 40%) was obtained in the skin. To determine the efficiency of excision mediated by Cre-ERT in a given cell type, we have now crossed Cre-ERT-expressing mice with reporter mice in which expression of Escherichia coli beta-galactosidase can be induced through Cre-mediated recombination. The efficiency and kinetics of this recombination were analyzed at the cellular level in the epidermis of 6- to 8-week-old double transgenic mice. We show that site-specific excision occurred within a few days of tamoxifen treatment in essentially all epidermis cells expressing Cre-ERT. These results indicate that cell-specific expression of Cre-ERT in transgenic mice can be used for efficient tamoxifen-dependent, Cre-mediated recombination at loci containing loxP sites to generate site-specific somatic mutations in a spatio-temporally controlled manner.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-2164640, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-2269655, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-2660363, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-2783482, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-3287623, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-7624356, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-7660125, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-7816809, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8016642, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8620528, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8698848, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8855277, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8962131, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-8980237, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-9108159, http://linkedlifedata.com/resource/pubmed/commentcorrection/9405652-9171115
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
23
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14559-63
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
pubmed:affiliation
Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Louis Pasteur, Collège de France, Strasbourg, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't